Prot #AP20151107: A Phase IIa, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy of CRTh2 Antagonist AZD1981 in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Project: Research project

Project Details

StatusFinished
Effective start/end date12/22/15 → 1/31/21

Funding

  • AstraZeneca Pharmaceuticals LP (Prot #AP20151107)